IN8bio Inc [INAB] stock is trading at $2.01, up 6.35%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INAB shares have gain 24.07% over the last week, with a monthly amount drifted -4.29%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
IN8bio Inc [NASDAQ: INAB] stock has seen the most recent analyst activity on March 18, 2024, when Laidlaw initiated its Buy rating and assigned the stock a price target of $7.50. Previously, H.C. Wainwright started tracking the stock with Buy rating on August 30, 2022, and set its price target to $14.
IN8bio Inc [INAB] stock has fluctuated between $1.53 and $12.53 over the past year. Currently, Wall Street analysts expect the stock to reach $4 within the next 12 months. IN8bio Inc [NASDAQ: INAB] shares were valued at $2.01 at the most recent close of the market. An investor can expect a potential return of 99.0% based on the average INAB price forecast.
Analyzing the INAB fundamentals
Gross Profit Margin for this corporation currently stands at -0.64% with Operating Profit Margin at -8.2%, Pretax Profit Margin comes in at -8.18%, and Net Profit Margin reading is -8.18%. To continue investigating profitability, this company’s Return on Assets is posted at -1.23, Equity is -1.46 and Total Capital is -1.38. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.9000 points at the first support level, and at 1.7900 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.1000, and for the 2nd resistance point, it is at 2.2000.
Ratios To Look Out For
For context, IN8bio Inc’s Current Ratio is 6.91. Also, the Quick Ratio is 6.91, while the Cash Ratio stands at 6.28.
